| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.69B | 43.92B | 13.65B | 13.90B | 11.35B | 11.45B |
| Gross Profit | 8.61B | 8.31B | 8.37B | 7.42B | 6.42B | 6.58B |
| EBITDA | 11.24B | 10.89B | 8.70B | 8.77B | 7.05B | 7.25B |
| Net Income | 8.59B | 8.43B | 6.18B | 6.28B | 4.55B | 4.70B |
Balance Sheet | ||||||
| Total Assets | 237.89B | 197.81B | 205.76B | 220.93B | 198.85B | 200.78B |
| Cash, Cash Equivalents and Short-Term Investments | 27.23B | 27.16B | 2.09B | 6.08B | 7.07B | 7.36B |
| Total Debt | 126.60B | 87.90B | 92.90B | 105.60B | 94.20B | 94.50B |
| Total Liabilities | 137.95B | 97.69B | 103.84B | 117.05B | 103.64B | 103.97B |
| Stockholders Equity | 99.94B | 100.11B | 101.92B | 103.88B | 95.21B | 96.81B |
Cash Flow | ||||||
| Free Cash Flow | -28.91B | 30.51B | 15.76B | -14.11B | 5.46B | 5.42B |
| Operating Cash Flow | 25.06B | 37.92B | 17.03B | 21.36B | 6.25B | 6.47B |
| Investing Cash Flow | -53.97B | -7.60B | -369.71M | -35.87B | 217.97M | -1.05B |
| Financing Cash Flow | 24.56B | -15.24B | -20.84B | 13.76B | -6.49B | -4.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥135.97B | 17.58 | ― | 6.26% | -17.50% | -15.10% | |
71 Outperform | ¥517.78B | 19.19 | ― | 4.10% | 5.25% | 19.44% | |
66 Neutral | ¥117.01B | 12.15 | ― | 5.86% | -11.45% | 33.70% | |
66 Neutral | ¥827.41B | 22.21 | 6.59% | 3.83% | -4.44% | -3.43% | |
66 Neutral | ¥1.07T | 24.59 | 5.94% | 3.40% | -14.70% | -7.58% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | ¥297.72B | 20.70 | ― | 3.94% | 30.30% | -25.37% |